Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover 30625, Germany.
Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover 30625, Germany; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Hannover 30625, Germany; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover 30625, Germany.
J Sport Health Sci. 2023 Jul;12(4):438-463. doi: 10.1016/j.jshs.2023.02.006. Epub 2023 Mar 2.
Coronaviruses are pathogens thought to primarily affect the respiratory tracts of humans. The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019 was also marked mainly by its symptoms of respiratory illness, which were named coronavirus disease 2019 (COVID-19). Since its initial discovery, many other symptoms have been linked to acute SARS-CoV-2 infections as well as to the long-term outcomes of COVID-19 patients. Among these symptoms are different categories of cardiovascular diseases (CVDs), which continue to be the main cause of death worldwide. The World Health Organization estimates that 17.9 million people die from CVDs each year, accounting for ∼32% of all deaths globally. Physical inactivity is one of the most important behavioral risk factors for CVDs. The COVID-19 pandemic has affected CVDs as well as the physical activity in different ways. Here, we provide an overview of the current status as well as future challenges and possible solutions.
冠状病毒被认为主要影响人类的呼吸道。2019 年严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）的爆发也主要以呼吸道疾病的症状为特征，被称为 2019 年冠状病毒病（COVID-19）。自最初发现以来，许多其他症状也与急性 SARS-CoV-2 感染以及 COVID-19 患者的长期预后有关。这些症状包括不同类别的心血管疾病（CVDs），它们仍然是全球死亡的主要原因。世界卫生组织估计，每年有 1790 万人死于 CVDs，占全球总死亡人数的约 32%。身体活动不足是 CVDs 的最重要行为风险因素之一。COVID-19 大流行以不同的方式影响了 CVDs 和身体活动。在这里，我们提供了当前状况以及未来挑战和可能解决方案的概述。
